Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New antitumor series developed at Daiichi

Dec. 10, 1998

Aronex files first NDA for orphan drug for APL

Dec. 9, 1998

Banyu conducts PK and metabolic studies of topoisomerase I inhibitor

Dec. 9, 1998

CoCensys patents key cell death gene, will license the technology out

Dec. 9, 1998

Preliminary report of therapeutic efficacy with 506U78 in leukemia patients

Dec. 8, 1998

Hughes Institute studying BTK-specific inhibitor LFM-A13

Dec. 8, 1998

Xcellerate-based therapy shows promising results in otherwise untreatable cancer patients

Dec. 8, 1998

PSC-833 plus chemotherapy is safe and effective in older patients with AML

Dec. 7, 1998

Isis patents antisense oligonucleotides for cancer treatment

Dec. 7, 1998

FDA approves Hycamtin as second-line treatment of small cell lung cancer

Dec. 4, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...